Correlation Between Puma Biotechnology and Psyence Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Puma Biotechnology and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Psyence Biomedical.

Diversification Opportunities for Puma Biotechnology and Psyence Biomedical

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Puma and Psyence is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Psyence Biomedical go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Psyence Biomedical

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.54 times more return on investment than Psyence Biomedical. However, Puma Biotechnology is 1.85 times less risky than Psyence Biomedical. It trades about 0.01 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.1 per unit of risk. If you would invest  398.00  in Puma Biotechnology on September 14, 2024 and sell it today you would lose (106.00) from holding Puma Biotechnology or give up 26.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Puma Biotechnology  vs.  Psyence Biomedical Ltd

 Performance 
       Timeline  
Puma Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Psyence Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Puma Biotechnology and Psyence Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Puma Biotechnology and Psyence Biomedical

The main advantage of trading using opposite Puma Biotechnology and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.
The idea behind Puma Biotechnology and Psyence Biomedical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bonds Directory
Find actively traded corporate debentures issued by US companies